Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:FLDM

Fluidigm (FLDM) Stock Price, News & Analysis

About Fluidigm Stock (NASDAQ:FLDM)

Key Stats

Today's Range
N/A
50-Day Range
$3.27
$3.99
52-Week Range
N/A
Volume
60,126 shs
Average Volume
968,838 shs
Market Capitalization
$283.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Receive FLDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fluidigm and its competitors with MarketBeat's FREE daily newsletter.

FLDM Stock News Headlines

Here's what Wall Street expects from Fluidigm's earnings
T2 Biosystms Inc (TTOO)
Next opportunity for crypto millions
The floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto. But most investors are missing the real goldmine…
Standard BioTools (NASDAQ: FLDM)
See More Headlines

FLDM Stock Analysis - Frequently Asked Questions

Fluidigm Co. (NASDAQ:FLDM) released its earnings results on Sunday, November, 7th. The medical research company reported ($0.18) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.04. The medical research company had revenue of $28.50 million for the quarter. Fluidigm had a negative trailing twelve-month return on equity of 40.15% and a negative net margin of 45.36%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fluidigm investors own include Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Advanced Micro Devices (AMD), OPKO Health (OPK), Magnachip Semiconductor (MX), Sorrento Therapeutics (SRNE) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
11/07/2021
Today
10/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical Instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:FLDM
CUSIP
34385P10
Employees
615
Year Founded
N/A

Profitability

Net Income
$-59,240,000.00
Pretax Margin
-48.75%

Debt

Sales & Book Value

Annual Sales
$130.58 million
Book Value
$1.24 per share

Miscellaneous

Free Float
74,268,000
Market Cap
$283.76 million
Optionable
Optionable
Beta
1.14
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:FLDM) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners